Patents Assigned to Pharmalink International Limited
  • Patent number: 11654163
    Abstract: A combination or composition of mussel lipid and krill oil is disclosed, which is used to treat inflammation or pain. A process for preparing hill oil having a phospholipid content of about 50% or greater is also disclosed.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: May 23, 2023
    Assignee: PHARMALINK INTERNATIONAL LIMITED
    Inventors: Stephen Myers, Christopher Oliver
  • Patent number: 6921543
    Abstract: A method for modulating the immune response to an immunogen in a human or animal patient comprises administration to the patient of an immunogenically effective amount of the immunogen and an immunomodulatory effective amount of a lipid extract of Perna canaliculus or Mytilus edulis.
    Type: Grant
    Filed: September 21, 2001
    Date of Patent: July 26, 2005
    Assignee: Pharmalink International Limited
    Inventors: Larisa G Rudenko, Robert Borland, Anatoly Naychin
  • Patent number: 6346278
    Abstract: Anti-inflammatory, and particularly anti-arthritic, treatment of a human or animal patient comprises administration to the patient of an effective amount of a lipid extract of Perna canaliculus or Mytilus edulis.
    Type: Grant
    Filed: July 5, 2000
    Date of Patent: February 12, 2002
    Assignee: Pharmalink International Limited
    Inventors: Theodore Macrides, Nicolette Kalafatis
  • Patent number: 6083536
    Abstract: Anti-inflammatory, and particularly anti-arthritic, treatment of a human or animal patient comprises administration to the patient of an effective amount of a lipid extract of Perna canaliculus or Mytilus edulis.
    Type: Grant
    Filed: May 5, 1998
    Date of Patent: July 4, 2000
    Assignee: Pharmalink International Limited
    Inventors: Theodore Macrides, Nicolette Kalafatis